« Return to News | Drug Sponsors

Covidien could be selling pharma unit

Wednesday, June 8, 2011 02:51 PM

Covidien is looking to sell its pharmaceuticals unit for as much as $4 billion, according to a source familiar with the situation, Reuters has reported.

JPMorgan Chase is advising Covidien on the matter, said the source, who declined to be named because the information was not public.

Covidien may decide to keep the drugs unit if the auction fails to generate high-enough offers, the source said.

The Mansfield, Mass.-based maker of surgical products, drugs and medical supplies had been in talks with another healthcare company for its drugs business, but those talks failed, according to a report by Bloomberg.

In April, Covidien reported a higher-than-expected second-quarter profit, helped by strong demand for its medical devices, and raised its full-year revenue growth forecast.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.